Sexual transmission of human T-cell lymphotropic virus type 1

Imagem de Miniatura
Arquivos
art_PAIVA_Sexual_transmission_of_human_Tcell_lymphotropic_virus_type_2014.PDF (775.86 KB)
Citações na Scopus
45
Tipo de produção
article
Data de publicação
2014
DOI
SciELO
Scopus
Web of Science
Título da Revista
ISSN da Revista
Título do Volume
Editora
SOC BRASILEIRA MEDICINA TROPICAL
Autores
Citação
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, v.47, n.3, p.265-274, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Human T-cell lymphotropic virus type 1 (HTLV-1) is endemic in many parts of the world and is primarily transmitted through sexual intercourse or from mother to child. Sexual transmission occurs more efficiently from men to women than women to men and might be enhanced by sexually transmitted diseases that cause ulcers and result in mucosal ruptures, such as syphilis, herpes simplex type 2 (HSV-2), and chancroid. Other sexually transmitted diseases might result in the recruitment of inflammatory cells and could increase the risk of HTLV-1 acquisition and transmission. Additionally, factors that are associated with higher transmission risks include the presence of antibodies against the viral oncoprotein Tax (anti-Tax), a higher proviral load in peripheral blood lymphocytes, and increased cervicovaginal or seminal secretions. Seminal fluid has been reported to increase HTLV replication and transmission, whereas male circumcision and neutralizing antibodies might have a protective effect. Recently, free virions were discovered in plasma, which reveals a possible new mode of HTLV replication. It is unclear how this discovery might affect the routes of HTLV transmission, particularly sexual transmission, because HTLV transmission rates are significantly higher from men to women than women to men.
Palavras-chave
Deltaretrovirus, Human T-cell lymphotropic virus type 1, Sexually transmitted diseases
URI
https://observatorio.fm.usp.br/handle/OPI/8846
Referências
  1. Andrade-Rocha FT, 1996, REV BRAS AN CLIN, V28, P171
  2. Araujo A, 2004, ANN NEUROL, V56, P10, DOI 10.1002/ana.20126
  3. Araya N, 2011, ANTIVIR THER, V16, P89, DOI 10.3851/IMP1699
  4. Beilke MA, 2004, CLIN OUTCOMES DIS PR, V39, P253
  5. Belec L, 1996, AIDS RES HUM RETROV, V12, P157, DOI 10.1089/aid.1996.12.157
  6. Berini CA, 2007, J MED VIROL, V79, P1914, DOI 10.1002/jmv.21036
  7. Cabral F, 2012, VIRUS RES, V163, P87, DOI 10.1016/j.virusres.2011.08.014
  8. Callatini S, 2005, RETROVIROLOGY, V2, P30
  9. Carneiro-Proietti Anna Bárbara F, 2002, Rev Soc Bras Med Trop, V35, P499, DOI 10.1590/S0037-86822002000500013
  10. Carneiro-Proietti ABF, 2006, REV PANAM SALUD PUBL, V19, P44, DOI 10.1590/S1020-49892006000100007
  11. Catalan-Soares BC, 2001, REV BRASILEIRA EPIDE, V4, P81, DOI 10.1590/S1415-790X2001000200003
  12. Caterino-de-Araujo A, 1994, EUR J EPIDEMIOL, V10, P165, DOI 10.1007/BF01730366
  13. CHEN YMA, 1991, P NATL ACAD SCI USA, V88, P1182, DOI 10.1073/pnas.88.4.1182
  14. de The GD, 1993, AIDS RES HUM RETROV, V9, P3816
  15. DELAPORTE E, 1995, J ACQ IMMUN DEF SYND, V8, P511
  16. Dourado I, 1998, J ACQ IMMUN DEF SYND, V19, P426
  17. EHRLICH GD, 1989, BLOOD, V74, P1658
  18. Etzel A, 2001, J ACQ IMMUN DEF SYND, V26, P185, DOI 10.1097/00126334-200102010-00015
  19. FEIGAL E, 1991, J INFECT DIS, V164, P36
  20. Fujino T, 2000, J REPROD IMMUNOL, V47, P197, DOI 10.1016/S0165-0378(00)00054-1
  21. Gabet AS, 2000, ONCOGENE, V19, P4954, DOI 10.1038/sj.onc.1203870
  22. Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388
  23. Gessain A, 2013, VIROLOGY, V435, P187, DOI 10.1016/j.virol.2012.09.035
  24. GOTUZZO E, 1994, J INFECT DIS, V169, P754
  25. Guimaraes ML, 2001, J CLIN VIROL, V21, P143, DOI 10.1016/S1386-6532(01)00158-5
  26. Hall WW, 1996, J ACQ IMMUN DEF SYND, V13, P204
  27. Hino S, 2011, P JPN ACAD B-PHYS, V87, P152, DOI 10.2183/pjab.87.152
  28. Hisada M, 2002, CLIN INFECT DIS, V34, P1551, DOI 10.1086/340537
  29. Iga M, 2002, J INFECT DIS, V185, P691, DOI 10.1086/339002
  30. Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115
  31. ISHAK R, 1995, AIDS RES HUM RETROV, V11, P813, DOI 10.1089/aid.1995.11.813
  32. Ishak R, 2003, EPIDEMIOLOGICAL ASPE, V19, P901
  33. Iwanaga M, 2010, BLOOD, V116, P1211, DOI 10.1182/blood-2009-12-257410
  34. Jin J, 2010, VIRUSES-BASEL, V2, P601, DOI 10.3390/v2020601
  35. Jones KS, 2008, NAT MED, V14, P429, DOI 10.1038/nm1745
  36. KAJIYAMA W, 1986, J INFECT DIS, V154, P851
  37. KALYANARAMAN VS, 1982, SCIENCE, V218, P571, DOI 10.1126/science.6981847
  38. Kaplan JE, 1996, J ACQ IMMUN DEF SYND, V12, P193
  39. Kashima S, 2006, AIDS RES HUM RETROV, V22, P953, DOI 10.1089/aid.2006.22.953
  40. KHABBAZ RF, 1990, JAMA-J AM MED ASSOC, V263, P60, DOI 10.1001/jama.263.1.60
  41. Khabbaz RF, 1992, NEW ENGL J MED, V326
  42. KOMURIAN F, 1991, J VIROL, V65, P3770
  43. Lairmore MD, 2011, VIRUSES-BASEL, V3, P1131, DOI 10.3390/v3071131
  44. La Rosa AM, 2009, CLIN INFECT DIS, V49, P112, DOI 10.1086/599609
  45. Larsen O, 2000, J ACQ IMMUN DEF SYND, V25, P157, DOI 10.1097/00126334-200010010-00010
  46. LEE H, 1989, SCIENCE, V244, P471, DOI 10.1126/science.2655084
  47. LEE HH, 1990, J INFECT DIS, V162, P347
  48. Li HC, 2004, J INFECT DIS, V190, P1275, DOI 10.1086/423941
  49. Lopes BP, 2006, THESIS, P105
  50. Lowis GW, 2002, ANN EPIDEMIOL, V12, P46, DOI 10.1016/S1047-2797(01)00231-9
  51. Maloney EM, 2000, PEDIATR INFECT DIS J, V19, P560, DOI 10.1097/00006454-200006000-00014
  52. MANNS A, 1992, INT J CANCER, V51, P886, DOI 10.1002/ijc.2910510609
  53. Mayer KH, 2011, AM J REPROD IMMUNOL, V65, P308, DOI 10.1111/j.1600-0897.2010.00942.x
  54. Menna-Barreto M, 2005, SO BRAZIL CAD SAUDE, V21, P1947
  55. Ministerio da Saude, 1993, PORT 1 376 19 NOV 19
  56. Ministerio da Saude, 2003, COORD NAC DST AIDS H
  57. Montanheiro P, 2008, VIRUS RES, V135, P22, DOI 10.1016/j.virusres.2008.01.015
  58. Montanheito PA, 2005, BRAZ J MED BIOL RES, V38, P1643, DOI 10.1590/S0100-879X2005001100011
  59. Moriuchi M, 2001, J VIROL, V75, P192, DOI 10.1128/JVI.75.1.192-198.2001
  60. Moriuchi M, 2004, J VIROL, V78, P12709, DOI 10.1128/JVI.78.22.12709-12711.2004
  61. Murphy EL, 2004, J INFECT DIS, V190, P504, DOI 10.1086/422398
  62. Murphy EL, 2004, EMERG INFECT DIS, V10, P109
  63. MURPHY EL, 1989, ANN INTERN MED, V111, P555
  64. Mylonas I, 2010, ARCH GYNECOL OBSTET, V282, P493, DOI 10.1007/s00404-010-1559-1
  65. Nagai M, 1998, J NEUROVIROL, V4, P586, DOI 10.3109/13550289809114225
  66. NAKASHIMA K, 1995, AM J EPIDEMIOL, V141, P305
  67. Pais-Correia AM, 2010, NAT MED, V16, P83, DOI 10.1038/nm.2065
  68. Patterson BK, 2002, AM J PATHOL, V161, P867, DOI 10.1016/S0002-9440(10)64247-2
  69. Pepin J, 2010, CLIN INFECT DIS, V51, P777, DOI 10.1086/656232
  70. Perez WQ, 2007, REV CIENCIAS MED, V11, P28
  71. Pique C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00378
  72. POIESZ BJ, 1981, NATURE, V294, P268, DOI 10.1038/294268a0
  73. Primo J, 2009, BRAZ J MED BIOL RES, V42, P761, DOI 10.1590/S0100-879X2009005000008
  74. Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968
  75. Romer D, 2009, ANTIMICROB AGENTS CH, V53, P678, DOI 10.1128/AAC.01550-07
  76. Roucoux DF, 2005, J INFECT DIS, V191, P1490, DOI 10.1086/429410
  77. Roucoux DF, 2004, AIDS REV, V6, P144
  78. Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972
  79. Segurado AAC, 2002, MEM I OSWALDO CRUZ, V97, P329, DOI 10.1590/S0074-02762002000300009
  80. Shindo N, 2002, AIDS RES HUM RETROV, V18, P71, DOI 10.1089/088922202753394736
  81. Silva MTT, 2007, CLIN INFECT DIS, V44, P689, DOI 10.1086/510679
  82. Starling AL, 2010, THESIS FACULDADE MED, P75
  83. STUVER SO, 1993, J INFECT DIS, V167, P57
  84. SUGIMOTO M, 1993, EUR RESPIR J, V6, P938
  85. Toro C, 2005, J CLIN VIROL, V33, P65, DOI 10.1016/j.jcv.2004.10.004
  86. Toro C, 2005, J MED VIROL, V76, P268, DOI 10.1002/jmv.20331
  87. Turner CG, 2008, HIV MED S, V9, P22
  88. VERDIER M, 1989, J INFECT DIS, V160, P363
  89. WIGNALL FS, 1992, J MED VIROL, V38, P44, DOI 10.1002/jmv.1890380110
  90. Wolfe ND, 2005, P NATL ACAD SCI USA, V102, P7994, DOI 10.1073/pnas.0501734102
  91. WOLFF H, 1995, FERTIL STERIL, V63, P1143
  92. World Health Organization, 2012, IARC MONOGR EVAL CAR, V100, P1
  93. World Health Organization, 2010, WHO LAB MAN EX PROC
  94. Yamano Y, 2002, BLOOD, V99, P88, DOI 10.1182/blood.V99.1.88
  95. Zehender G, 2004, J MED VIROL, V74, P207, DOI 10.1002/jmv.20165
  96. ZELLA D, 1990, LANCET, V336, P575, DOI 10.1016/0140-6736(90)92140-D
  97. Zihlmann KF, 2009, THESIS DOUTORADO FAC, P367
  98. Zunt JR, 2006, AM J TROP MED HYG, V74, P922
  99. Zunt JR, 2002, J INFECT DIS, V186, P1669, DOI 10.1086/345364

Coleções
Artigos e Materiais de Revistas Científicas - IMT
Artigos e Materiais de Revistas Científicas - LIM/56
Artigos e Materiais de Revistas Científicas - ODS/03
Artigos e Materiais de Revistas Científicas - ODS/05